Literature DB >> 27247717

Imaging of peritoneal deposits in ovarian cancer: A pictorial review.

Sheragaru Hanumanthappa Chandrashekhara1, Gowramma Sannanaik Triveni1, Rahul Kumar1.   

Abstract

As per incidence, ovarian carcinoma is the second most common gynaecological malignancy in women. In spite of advanced technology, patient awareness and effective screening methods, epithelial ovarian cancer is usually diagnosed at an advanced stage (stage III). Surgical debulking of disease is mainstay of improving the patient survival even in advanced stages. Thus exact delineation of cancer spread in the abdominal cavity guides the surgeon prior to the surgery, help them to decide resectability of lesion and plan for further need of other surgical speciality or need of neoadjuvant chemotherapy. Imaging particularly well-planned contrast-enhanced computed tomography answers most of the queries raised by the treating surgeon. The aim of this article is to review the way ovarian carcinoma spread in the peritoneal cavity and to stress the accurate interpretation of cancer deposits on imaging which can help the treating team to reach optimal management of patients.

Entities:  

Keywords:  Computed tomography; Ovarian carcinoma; Peritoneal deposits

Year:  2016        PMID: 27247717      PMCID: PMC4882408          DOI: 10.4329/wjr.v8.i5.513

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  15 in total

Review 1.  Peritonectomy procedures.

Authors:  Paul H Sugarbaker
Journal:  Surg Oncol Clin N Am       Date:  2003-07       Impact factor: 3.495

Review 2.  ESUR guidelines: ovarian cancer staging and follow-up.

Authors:  Rosemarie Forstner; Evis Sala; Karen Kinkel; John A Spencer
Journal:  Eur Radiol       Date:  2010-09-14       Impact factor: 5.315

3.  What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?

Authors:  S M Eisenkop; N M Spirtos
Journal:  Gynecol Oncol       Date:  2001-09       Impact factor: 5.482

4.  Peritoneal carcinosis of ovarian origin.

Authors:  Anna Fagotti; Valerio Gallotta; Federico Romano; Francesco Fanfani; Cristiano Rossitto; Angelica Naldini; Massimo Vigliotta; Giovanni Scambia
Journal:  World J Gastrointest Oncol       Date:  2010-02-15

5.  Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT.

Authors:  R N Low; R M Barone; C Lacey; J S Sigeti; G D Alzate; C P Sebrechts
Journal:  Radiology       Date:  1997-08       Impact factor: 11.105

Review 6.  Surgical responsibilities in the management of peritoneal carcinomatosis.

Authors:  Paul H Sugarbaker
Journal:  J Surg Oncol       Date:  2010-06-15       Impact factor: 3.454

7.  Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.

Authors:  P-E Colombo; A Mourregot; M Fabbro; M Gutowski; B Saint-Aubert; F Quenet; S Gourgou; P Rouanet
Journal:  Eur J Surg Oncol       Date:  2008-03-04       Impact factor: 4.424

8.  Survival time, causes of death, and tumor/treatment-related morbidity in 100 women with ovarian cancer.

Authors:  P M Dvoretsky; K A Richards; C Angel; L Rabinowitz; J B Beecham; T A Bonfiglio
Journal:  Hum Pathol       Date:  1988-11       Impact factor: 3.466

9.  Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion.

Authors:  Oguz Akin; Evis Sala; Chaya S Moskowitz; Nicole Ishill; Robert A Soslow; Dennis S Chi; Hedvig Hricak
Journal:  Radiology       Date:  2008-06-02       Impact factor: 11.105

10.  Diagnosis and management of peritoneal metastases from ovarian cancer.

Authors:  Evgenia Halkia; John Spiliotis; Paul Sugarbaker
Journal:  Gastroenterol Res Pract       Date:  2012-07-19       Impact factor: 2.260

View more
  7 in total

1.  Ovarian cancer reporting lexicon for computed tomography (CT) and magnetic resonance (MR) imaging developed by the SAR Uterine and Ovarian Cancer Disease-Focused Panel and the ESUR Female Pelvic Imaging Working Group.

Authors:  Elizabeth A Sadowski; Atul B Shinagare; Hyesun Park; Olga R Brook; Rosemarie Forstner; Sumer K Wallace; Jeanne M Horowitz; Neil Horowitz; Marcia Javitt; Priyanka Jha; Aki Kido; Yulia Lakhman; Susanna I Lee; Lucia Manganaro; Katherine E Maturen; Stephanie Nougaret; Liina Poder; Gaiane M Rauch; Caroline Reinhold; Evis Sala; Isabelle Thomassin-Naggara; Herbert Alberto Vargas; Aradhana Venkatesan; Olivera Nikolic; Andrea G Rockall
Journal:  Eur Radiol       Date:  2021-11-30       Impact factor: 7.034

2.  Two-photon images reveal unique texture features for label-free identification of ovarian cancer peritoneal metastases.

Authors:  Dimitra Pouli; Elizabeth M Genega; Travis B Sullivan; Kimberly M Rieger-Christ; Valena Wright; Irene Georgakoudi; Thomas Schnelldorfer
Journal:  Biomed Opt Express       Date:  2019-08-06       Impact factor: 3.562

Review 3.  Fluorescent Nanoparticles for the Guided Surgery of Ovarian Peritoneal Carcinomatosis.

Authors:  Tristan Mangeolle; Ilya Yakavets; Sophie Marchal; Manon Debayle; Thomas Pons; Lina Bezdetnaya; Frédéric Marchal
Journal:  Nanomaterials (Basel)       Date:  2018-07-26       Impact factor: 5.076

4.  Human Ovarian Cancer Tumor Formation in Severe Combined Immunodeficient (SCID) Pigs.

Authors:  Adeline N Boettcher; Matti Kiupel; Malavika K Adur; Emiliano Cocco; Alessandro D Santin; Stefania Bellone; Sara E Charley; Barbara Blanco-Fernandez; John I Risinger; Jason W Ross; Christopher K Tuggle; Erik M Shapiro
Journal:  Front Oncol       Date:  2019-01-22       Impact factor: 6.244

5.  Metabolic active peritoneal sites affect tumor debulking in ovarian and peritoneal cancers.

Authors:  Tung Tung Tsoi; Keith W H Chiu; M Y Chu; Hextan Y S Ngan; Elaine Y P Lee
Journal:  J Ovarian Res       Date:  2020-05-20       Impact factor: 4.234

Review 6.  Recent Progress in Second Near-Infrared (NIR-II) Fluorescence Imaging in Cancer.

Authors:  Tian Wang; Yingying Chen; Bo Wang; Xiaofan Gao; Mingfu Wu
Journal:  Biomolecules       Date:  2022-07-28

Review 7.  Nutraceutical-Based Nanoformulations for Breast and Ovarian Cancer Treatment.

Authors:  Simona Serini; Roberta Cassano; Federica Curcio; Sonia Trombino; Gabriella Calviello
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.